Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug's first entry ...

Read on to learn more about Wegovy, a new obesity medication. Learn how it works, whether it may be right for you and important side effects and warnings.

Lured to Cambodia, tortured and forced to defraud strangers online, a Thai teenager said he barely survived after he threw ...

The launch in Thailand marks Wegovy’s entry into the Southeast Asian market. Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary, told Reuters that the firm ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

As of May 22, manufacturers are no longer allowed to distribute the compounded versions of semaglutide, which Novo Nordisk sells under the brand Wegovy for weight loss and Ozempic for diabetes.

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

Wegovy is a prescription drug used for long-term weight management. Learn about the side effects it can cause and how to manage them.

Dec. 4, 2024 – People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial. Those who took Zepbound lost on ...

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...

BANGKOK (Reuters) -Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug ...